Aspirin
- Generic Name
- Aspirin
- Brand Names
- Aggrenox, Alka-seltzer, Alka-seltzer Fruit Chews, Anacin, Arthriten Inflammatory Pain, Ascomp, Aspi-cor, Aspir-low, Bayer Aspirin, Bayer Womens, Bc Arthritis, Bc Original Formula, Bufferin, Duoplavin, Durlaza, Ecotrin, Ecpirin, Endodan Reformulated May 2009, Equagesic, Exaprin, Excedrin, Excedrin PM Triple Action, Fasprin, Fiorinal, Goody's Body Pain, Goody's Extra Strength, Goody's PM, Miniprin, Norgesic, Norgesic Forte, Orphengesic, Pamprin Max Formula, Robaxisal, ST. Joseph Aspirin, Stanback Headache Powder Reformulated Jan 2011, Trianal, Trianal C, Vanquish, Vazalore, Yosprala
- Drug Type
- Small Molecule
- Chemical Formula
- C9H8O4
- CAS Number
- 50-78-2
- Unique Ingredient Identifier
- R16CO5Y76E
- Background
Also known as Aspirin, acetylsalicylic acid (ASA) is a commonly used drug for the treatment of pain and fever due to various causes. Acetylsalicylic acid has both anti-inflammatory and antipyretic effects. This drug also inhibits platelet aggregation and is used in the prevention of blood clots stroke, and myocardial infarction (MI) .
...
- Indication
Pain, fever, and inflammation
...
- Associated Conditions
- Acute Coronary Syndrome (ACS), Anxiety, Atherothrombotic cerebral infarction, Cardiovascular Disease (CVD), Cardiovascular Events, Cardiovascular Mortality, Colorectal Adenomas, Colorectal Cancer, Common Cold, Coronary artery reocclusion, Death, Dyspeptic signs and symptoms, Fever, Flu caused by Influenza, Headache, Heterozygous Familial Hypercholesterolemia (HeFH), Inflammation, Juvenile Idiopathic Arthritis (JIA), Major Adverse Cardiovascular and Cerebrovascular Events (MACCE), Menstrual Pain, Migraine, Morbidity, Mucocutaneous Lymph Node Syndrome, Muscle Contraction, Myalgia, Myocardial Infarction, Myocardial Infarction (MI), first occurrence, Neuropathic Pain, Pain, Pain caused by Common Cold, Pain caused by Rheumatism, Pericarditis, Polycythemia Vera (PV), Pre-Eclampsia, Rheumatism, Rheumatoid Arthritis, Rhino Sinusitis, Severe Pain, Spondyloarthropathies, Stroke, Systemic Lupus Erythematosus, Tension Headache, Thromboembolism, Thrombosis, Toothache, Transient Ischemic Attack, Vascular Death, Venous Thromboembolism, Acute Inflammation, Articular inflammation, Atherothrombotic events, Death caused by Myocardial Infarction, Fever or influenza-like illness, Moderate Pain, Recurrent Ischemic Stroke
- Associated Therapies
- Anti-platelet Therapy, Hemodialysis Treatment, Secondary Prevention
The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic Stroke
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-12-23
- Last Posted Date
- 2022-12-29
- Lead Sponsor
- Shanghai Yueyang Integrated Medicine Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT05663307
- Locations
- 🇨🇳
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-12-09
- Last Posted Date
- 2022-12-09
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 80
- Registration Number
- NCT05644210
- Locations
- 🇨🇳
Qilu Hospital, Jinan, Shandong, China
Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-12-05
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- German Cancer Research Center
- Target Recruit Count
- 170
- Registration Number
- NCT05637567
COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-12-01
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- Montreal Heart Institute
- Target Recruit Count
- 10000
- Registration Number
- NCT05633810
- Locations
- 🇨🇦
Montreal Heart Institute, Montréal, Quebec, Canada
Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology
- First Posted Date
- 2022-11-23
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 1164
- Registration Number
- NCT05625724
- Locations
- 🇫🇷
CHRU Nancy, Nancy, France
🇫🇷Hôpital Armand - Trousseau, Paris, France
🇫🇷CHU Bordeaux, Bordeaux, France
Study to Compare the Pharmacodynamics and Pharmacokinetics of Acetylsalicylic Acid Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Healthy Adults.
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-11-22
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Vectura, Inc.
- Target Recruit Count
- 86
- Registration Number
- NCT05625334
- Locations
- 🇺🇸
Sinai Hospital, Baltimore, Maryland, United States
🇺🇸Bio-Kinetic Clinical Applications, LLC dba QPS-MO, Springfield, Missouri, United States
Platelet Enzymatically Oxidized Phospholipids (eoxPL) Characterisation in a Healthy Cohort on and Off Aspirin
- First Posted Date
- 2022-11-03
- Last Posted Date
- 2022-11-03
- Lead Sponsor
- Cardiff University
- Target Recruit Count
- 28
- Registration Number
- NCT05604118
- Locations
- 🇬🇧
Sir Geraint Evans Cardiovascular Research Building, Cardiff, United Kingdom
COMParison of the EffecT of dEvice Closure in Alleviating Migraine With PFO (COMPETE-2)
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-09-30
- Last Posted Date
- 2023-01-09
- Target Recruit Count
- 460
- Registration Number
- NCT05561660
- Locations
- 🇨🇳
Fuwai Hospital, Beijing, Beijing, China
Assess Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban in Healthy Adult Participants
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-09-21
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- Regeneron Pharmaceuticals
- Target Recruit Count
- 60
- Registration Number
- NCT05546957
- Locations
- 🇬🇧
LabCorp CRU, Leeds, West Yorkshire, United Kingdom
Antiplatelet Effect of Ginkgo Diterpene Lactone Meglumine Injection in Acute Ischemic Stroke
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-09-08
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- Shanghai Yueyang Integrated Medicine Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT05531942
- Locations
- 🇨🇳
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath